Business Description
DSM-Firmenich AG
ISIN : CH1216478797
Total Employee Number:
26,983Compare
Compare
Traded in other countries / regions
DSFIR.NetherlandsDSFIR.Switzerland0AC9.UKDSFIY.USADSFI.AustriaZX6.GermanyDSFIR N.Mexico IPO Date
2023-04-28Description
DSM-Firmenich is a global science-based company formed in 2023 through the merger of DSM, a Dutch nutrition, health, and sustainable living player, and Switzerland-based Firmenich, the third-largest player in the flavor and fragrance market. The company serves a wide range of end-consumer markets providing nutrition solutions ranging from medical and early-life nutrition, fragrances for personal-, home-, and laundry-care brands, prestige perfumes, and other ingredients for food and beverage, home, and personal care. DSM-Firmenich has nearly 30,000 employees, with more than 2,000 scientists and engineers spread across 15 research and development facilities.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.36 | |||||
Equity-to-Asset | 0.62 | |||||
Debt-to-Equity | 0.29 | |||||
Debt-to-EBITDA | 1.37 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 2.01 | |||||
Beneish M-Score | -3.29 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -22.9 | |||||
3-Year EBITDA Growth Rate | 37.6 | |||||
3-Year EPS without NRI Growth Rate | -17 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 87.61 | |||||
9-Day RSI | 80.53 | |||||
14-Day RSI | 78.57 | |||||
3-1 Month Momentum % | 25 | |||||
6-1 Month Momentum % | 3.89 | |||||
12-1 Month Momentum % | -22.11 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.59 | |||||
Quick Ratio | 1.21 | |||||
Cash Ratio | 0.34 | |||||
Days Inventory | 191.5 | |||||
Days Sales Outstanding | 96.97 | |||||
Days Payable | 131.57 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 3.3 | |||||
Dividend Payout Ratio | 2.09 | |||||
Forward Dividend Yield % | 3.3 | |||||
5-Year Yield-on-Cost % | 3.3 | |||||
3-Year Average Share Buyback Ratio | -18.6 | |||||
Shareholder Yield % | 6.94 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 39.08 | |||||
Operating Margin % | 7 | |||||
Net Margin % | -11.97 | |||||
EBITDA Margin % | 42.61 | |||||
FCF Margin % | 7.3 | |||||
OCF Margin % | 16.12 | |||||
ROE % | -5.22 | |||||
ROA % | -3.4 | |||||
ROIC % | 1.85 | |||||
ROC (Joel Greenblatt) % | 9.12 | |||||
ROCE % | 2.66 | |||||
Years of Profitability over Past 10-Year | 3 | |||||
Moat Score | 6 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 22.61 | |||||
PE Ratio without NRI | 66.1 | |||||
PS Ratio | 2.31 | |||||
PB Ratio | 1.1 | |||||
Price-to-Tangible-Book | 7.03 | |||||
Price-to-Free-Cash-Flow | 31.21 | |||||
Price-to-Operating-Cash-Flow | 14.22 | |||||
EV-to-EBIT | 32.12 | |||||
EV-to-Forward-EBIT | 25.5 | |||||
EV-to-EBITDA | 6.07 | |||||
EV-to-Forward-EBITDA | 12.96 | |||||
EV-to-Revenue | 2.58 | |||||
EV-to-Forward-Revenue | 2.52 | |||||
EV-to-FCF | 35.87 | |||||
Price-to-GF-Value | 1.05 | |||||
Price-to-Graham-Number | 4.55 | |||||
Earnings Yield (Greenblatt) % | 3.11 | |||||
FCF Yield % | 3.29 |
DSM-Firmenich AG Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
DSM-Firmenich AG Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-10-30 | In 124 days | ||
| Second quarter earnings conference call for 2026 | 2026-07-30 | In 32 days | ||
| Second quarter earnings results for 2026 | 2026-07-30 | In 32 days | ||
| EUR 2.500000 Cash Dividend | 2026-05-11 | 72.75 (+0.00%) | ||
| General meeting for 2026 | 2026-05-07 | 72.75 (+0.00%) | ||
| Annual report for 2025 | 2026-02-23 | 77.42 (+0.00%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-12 09:00 | 77.42 (+0.00%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-12 | 77.42 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-10-30 | 86.21 (+0.00%) | ||
| Second quarter earnings conference call for 2025 | 2025-07-31 09:00 | 100.00 (+0.00%) |
Show
Entries
Guru Commentaries on OTCPK:DSMFF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on DSM-Firmenich AG
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers